As the results show, administration of TGF-β to mice reduced shrunken neurons with pyknotic nuclei, which means that TGF-β may be a strong candidate as a future adjunctive therapy in the treatment of acute bacterial meningitis. This evidence concerns the gene TGFB1 and bacterial meningitis.